8.61 USD
↘ 0.23 (2.60%)AT CLOSE (AS OF 07:31 PM EDT)
Kyverna Therapeutics, Inc. Common Stock
KYTXNASDAQ • USD
Market: CLOSED
Kyverna Therapeutics, Inc. Common Stock (KYTX) trades at $8.61 per share. KYTX shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, KYTX trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Aug 26, 2026.
Open?$8.81
High?$8.84
Low?$8.50
Prev. Close?$8.84
Volume?413.8K
Avg. Volume?832.2K
VWAP?$8.69
Rel. Volume?0.50x
Bid / Ask
Bid?$7.02 × 100
Ask?$9.90 × 100
Spread?$2.88
Midpoint?$8.46
Valuation & Ratios
Market Cap?546.7M
Shares Out?61.8M
Float?36.8M
Float %?60.5%
P/E Ratio?N/A
P/B Ratio?3.30
EPS?-$2.47
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
Themes
Employees
149
Market Cap
546.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-02-08
Address
5980 HORTON STREET
EMERYVILLE, CA
Phone: (510) 925-2492
EMERYVILLE, CA
Phone: (510) 925-2492
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?20
Momentum?77
Short Sent.?39
Piotroski F-Score?0/9Weak
Altman Z-Score?1.46Distress
Confidence?50%Low
Short InterestSqueeze Risk
Short % of Float?23.11%Squeeze Risk
Short Interest?8.5M
Days to Cover?13.3
Free Float36.8M
Avg Daily Volume636.9K
Settlement Date2026-08-14
Financial Health
Current Ratio?9.06Strong
Quick Ratio?9.06Strong
Cash Ratio?1.39Strong
Debt/Equity?0.15Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?3.30FAIR▾
Peers100
S&P51
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-92.2%WEAK▾
S&P3
ROA?-69.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-159045000
Enterprise Value?$539.9M
Fundamentals ratios updated end of day